Pipeline to NAV

Pipeline to NAV

Figures converted from Indian rupees at historical FX rates — see data/company.json.fx_rates for the rate table; this present-value chapter uses a single current rate (₹1 = $0.01039) throughout for internal consistency. Ratios, margins, and multiples are unitless and unchanged.

Sunteck's value case is an asset case, not an earnings one — a 5.6% return on equity does not justify the price, so the question is what the $4.26B development pipeline is worth to a shareholder. On a disciplined bridge, Sunteck's $4.26B pipeline is worth roughly $4.57 a share (range $3.79-$5.59) against a $3.27 price, so the fallen-star discount is real but far narrower than the raw 10%-of-GDV framing suggests. Gross development value is a multi-year, gross sale figure, not value in hand: at the FY26 pre-sales run-rate it is roughly 13 years of selling; four brokers, working independently, cluster at $5.45–$5.64.

What "GDV" actually is

Sunteck frames its pipeline as gross development value: $4.58B gross of pre-sales, or a balance $4.26B excluding sales already booked, across roughly 50 million square feet [1] [2]. That balance has nearly tripled in four years, from $1.42B in FY22 [3].

Source: Q4 FY2026 investor presentation, GDV portfolio detail [4].

Three properties of that number decide how much of it a shareholder ever sees. First, it is gross sale value, not profit: against it sit land payments still owed, roughly a decade of construction cost, and tax. Second, most of the portfolio is built on joint-development agreements — 36 of the ~50 million square feet [5] — where Sunteck keeps only a "constructed area share" negotiated with each landowner, a split the auditor tests project by project [6]. Third, it is realised slowly. Against FY26 pre-sales of $328M, the balance pipeline is about 13 years of selling at the current run-rate [7]. Even if pre-sales keep compounding in the low-20s percent, the tail runs the better part of a decade — which is why an undiscounted $4.26B overstates present value.

The book already tells you the land was cheap relative to its selling ambition: at FY25 the group carried land and development rights of $314M against a $4.09B GDV — under 8% — all of it held "at cost or net realisable value, whichever is less" [8]. By FY26 total inventory had grown to $820M, still at cost. The gap between that cost basis and the pipeline's sale value is the development surplus — the thing a valuation has to size and then discount.

Sizing the surplus

Sunteck does not publish a net asset value; the closest management gets is a 2023 "intrinsic value" slide that added seven residential "growth engines" worth $3.15B of GDV to two pre-leased BKC commercial assets carrying ~$109M of capital value and ~$5M of annual rent [9]. That is a GDV tally, not a per-share value. Building the bridge is left to the analyst.

The honest way to do it is to convert GDV into the post-tax profit it can throw off, discount that back, and add it to the capital already invested. Sunteck's FY26 economics give the margin anchor: a 27% EBITDA margin, a 23.8% pre-tax margin, and an 18.0% net margin [10]. Applying a post-tax margin to Sunteck's economic share of the balance GDV gives the pipeline's cumulative profit; a present-value factor collapses it for the decade-long realisation; adding the owners' equity already on the books — $375M, which funds the inventory at cost, net of debt and minorities [11] — yields net asset value to shareholders.

Source: derived from FY2026 balance GDV, margins and equity [12] [13] [14]; values in $ per share.

The grid runs from $3.79 to $5.59 a share, with a central case near $4.57 — comfortably above the $3.27 price, and most sensitive to the realised margin and the monetisation speed. Two commercial annuity assets in BKC add a modest slice on top: Equirus values the annuity stream, then ~$7M a year and expected to grow roughly fivefold, as a separate SOTP leg, and management's own 2023 mark put their capital value near $109M [15]. Held conservatively, that is worth another $0.42–$0.73 a share; it is not the crux.

What the market pays for the pipeline

The market's own arithmetic frames the gap cleanly. At $3.27, the $474M market capitalisation is $375M of owners' book equity plus a $99M premium — and that premium is everything the market is paying for the entire future development surplus on a $4.26B pipeline [16]. That is 2.3% of balance GDV, and about $0.69 a share. Set against Sunteck's own 18% net margin, the market is discounting the pipeline's profit far below even the slow-monetisation corner of the grid above.

Sources: price and NAV bridge derived above; broker sum-of-the-parts targets — Equirus $5.64, Motilal Oswal $5.51, Nuvama $5.52 — per published broker research; $5.37 is the 12-analyst consensus mean, per consensus estimates.

The outside marks

The independent NAV work agrees on direction. Four houses run explicit sum-of-the-parts or NAV valuations and land tightly together: Equirus initiated at $5.64 on a March-2026 SOTP of the residential pipeline plus BKC annuity plus a debt-free balance sheet; Motilal Oswal carries $5.51; Nuvama $5.52, trimmed from $5.82 on "MMR caution" and a rollover to a later base year. The 12-broker consensus mean sits at $5.37 (+64% over $3.27), with all twelve rated buy or strong-buy and none neutral or negative, per consensus estimates. My own conservative bridge (central ~$4.57) sits below that cluster, which is the useful signal: the brokers reach $5.45–$5.64 by assuming margins hold near 18–20%, monetisation is quick, and the annuity and future business development all count. Those are the assumptions the range is most sensitive to.

Why the discount could be earned

A NAV above price is not, by itself, a reason the price is wrong — the same bridge run pessimistically closes the gap, and the market may be pricing the pessimistic branch on purpose.

Four facts keep that branch live. The record year still earned only about 5.6% on average equity — $21M of profit [17] against a $465M net worth [18] — so nothing in the current income statement forces a re-rating. The business consumed cash to grow — FY26 net operating cash flow was negative as $85M went into land and business development, funded by a capital raise, so the pipeline's expansion is real but self-financing it is not yet proven (Financials and Estimates). The inventory that anchors owners' equity is carried at cost, and its recoverable value is the auditor's standing key audit matter — an MMR downturn would test the net-realisable-value floor before it tests the surplus [19]. And the reported $28M net debt is struck only after crediting back $40M of "loans to JDA partners"; on gross debt of $78M less $10M cash, the balance-sheet cushion under the NAV is thinner than the 0.06x headline suggests [20].

There is also the insiders' own signal. When promoters re-upped in FY26 they priced their warrants at $4.42 — essentially the regulatory floor, not a premium (Skin in the Game). People who believed intrinsic value sat at $5.45 did not pay up to say so.

What would move the read is narrow and checkable: the realised margin on each newly launched phase (holding near 18% versus drifting toward the low-teens), the pace at which balance GDV converts to collections (compressing the 13-year run-rate), and whether operating cash flow turns positive once the FY26 land spend seasons. The pipeline is large and cheaply carried; whether it is worth $4.57 or $3.27 depends on how much of $4.26B becomes shareholder cash, and how soon.